De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
Royal Marsden NHS Foundation Trust
UNC Lineberger Comprehensive Cancer Center
Merck Sharp & Dohme LLC
UNC Lineberger Comprehensive Cancer Center
University of Maryland, Baltimore
NRG Oncology
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
University of Kentucky
University of Arkansas
Sanford Health
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Dana-Farber Cancer Institute
University of Pittsburgh
Numab Therapeutics AG
Memorial Sloan Kettering Cancer Center
University of Chicago
M.D. Anderson Cancer Center
Galderma R&D
Regeneron Pharmaceuticals
Henry Ford Health System
LEO Pharma
University of Pittsburgh
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Washington University School of Medicine
University of Arizona
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
University of Pittsburgh
University of Oxford
Federation Francophone de Cancerologie Digestive
Advaxis, Inc.
Advaxis, Inc.
UNC Lineberger Comprehensive Cancer Center
Pfizer
Galera Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Pfizer
Genmab
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
University of Wisconsin, Madison